Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Cost–benefit analysis of the National Immunization Program in Spain
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimabnin Spain
VOL 9 – NÚM 1 – ABRIL 2024. INNOVACIÓN TERAPÉUTICA EN EERR
VOL 8 – NÚM 3 – DICIEMBRE 2023. POLÍTICAS NACIONALES E INTERNACIONALES
The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
La utilidad del número necesario de pacientes a largo plazo a tratar para evaluar las terapias inhibidoras de las interleucinas 17 y 23 en el tratamiento de la psoriasis en placas de moderada a grave
